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Introduction
Benign prostatic hyperplasia is a major cause of lower urinary tract symptoms (LUTS) in males, and it affects about 210 million people worldwide. 1 However, the fact that prostate size has no remarkable association with the severity of the symptoms has been reported in several studies 2, 3 There are some other anatomic factors that have also been considered as possible factors affecting the severity of the symptoms, for example, transitional zone index and the intravesical prostatic protrusion (IPP). 4e6 Kuo 7 also established a clinical prostate score by using the simple parameters of uroflowmetry and transrectal ultrasonography (TRUS) measurements that can conveniently diagnose benign prostate obstruction of male LUTS with a good sensitivity and specificity. Recently, the prostatic urethral angle (PUA) has been regarded as a possible factor affecting male LUTS. 8 As demonstrated by Cho et al, 9 the prostatic urethra is a bent-formed tube, and the kinetic energy of the voiding urine would decrease because of the angle during micturition. The greater the angle, the greater the amount of kinetic energy that would be lost. 9 A mathematical simulation has been created to demonstrate the relationship between the urinary flow rate and PUA. 8 The equation is as follows:
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 2p where d represents the prostatic urethra diameter, p represents the vesical pressure, Q is the urine flow rate, and q is the PUA. As shown in the equation, the greater the angle of q, the lower Q becomesdthat is, the urinary flow rate is inversely associated with PUA. However, this hypothesis, which is based on mathematical simulation, requires further clinical observation in order to be confirmed. The purpose of our study was to clarify the influence of PUA on the peak flow rate (Q max ), the severity of LUTS, and the amount of postvoid residual urine.
Materials and methods
From October 2012 to February 2014, the records of first-visit male patients with LUTS who agreed to undergo TRUS and uroflowmetry prior to receiving treatment in our institution were obtained. These patients underwent a detailed medical history taking and physical examination. They were excluded if they had any evidence of neurologic disorder that could affect voiding function, uncontrolled diabetes mellitus, or any malignant disease. Those found to have a history of prostate surgery, presenting with indwelling urinary catheter, having dementia or any disability that could interfere with verbal communication were excluded as well. Patients who had already taken alpha blockers were also excluded. All the chosen participants were verbally informed of the purpose and the entire procedure involved in performing TRUS, uroflowmetry study, and International Prostate Symptom Score (IPSS) evaluation. A total of 227 patients were included in the study.
A transrectal ultrasound was performed on these patients by a single urologist using a single ultrasound machine (SSD-A6, ALOKA), with a 7.5-MHz biplanar transrectal probe. All patients in our study had a full bladder when undergoing TRUS examination. The ellipse formula (length Â width Â height Â 0.52) was used to measure the size of the prostate volume. PUA, as illustrated in Fig. 1A , was defined as the angle formed by the proximal prostate urethra and distal prostate urethra, as suggested by Cho et al. 8 IPP,
as illustrated in Fig. 1B , was measured from the tip of the protruding prostate into the bladder to the bladder circumference at the prostate base in the sagittal plane, as suggested by Nose et al. 10 The IPSS 11 of the patients were also recorded by a single qualified urologist during the medical history taking. Uroflowmetry and a bladder scan for the postvoiding residual urine were performed on every patient. The ManneWhitney test was used to compare the PUA according to IPSS and Q max . Multivariate linear regression analysis was performed to analyze the independent association of the patients' parameters with Q max , IPSS scores, and the postvoiding residual urine. SPSS version 15.0 (SPSS, Inc., Chicago, IL, USA) was applied for statistical analysis. All statistical tests were conducted with a significance level of p ¼ 0.05.
Results
The subject characteristics of the patients are summarized in Table 1 . A total of 227 patients were included in our study. The mean age of the patients was 65.88 ± 9.49 years. The mean total prostate volume was 39.39 ± 19.79 mL, and the mean PUA was 44.58 ± 12.87 . The mean IPSS, mean Q max , mean voiding volume, and mean postvoiding residual urine volume were 17.05 ± 4.54 mL, 7.47 ± 2.60 mL/second, 222.41 ± 66.35 mL, and 32.40 ± 37.62 mL, respectively. Table 2 outlines a comparison of PUA and IPP according to IPSS. We can see that the mean PUA of the patients whose IPSS scores are 20 is 40.83 , whereas that of patients whose IPSS scores are > 20 is 55.95 . There are significant differences between the two groups (p < 0.001). Meanwhile, the mean IPP of patients whose IPSS scores are 20 is 3.99 mm, whereas that of patients whose IPSS scores are ! 20 is 7.05 mm. There are significant differences between the two groups as well (p < 0.001). Table 3 shows a comparison of PUA and IPP according to Q max . We can see that the mean PUA of the patients whose Q max are < 10 mL/second is 45.28 , whereas that of patients whose Q max ! 10 is 41.18 (p ¼ 0.016). There are significant differences between the two groups. Meanwhile, the mean IPP of the patients whose Q max are < 10 mL/second is 5.15 mm, whereas that of patients whose Q max ! 10 is 3.33 mm (p ¼ 0.159). This finding indicates that there is no significant difference between the two groups. Table 4 reveals the relationship between IPSS and the independent prostatic parameters. We find that PUA has a very strong correlation with IPSS, whether regarding total scores (p < 0.001), voiding symptom scores (p < 0.001), or storage symptom scores (p ¼ 0.005). Although total prostate volume has no remarkable correlation with IPSS total scores (p ¼ 0.143) and storage symptom score (p ¼ 0.123), there was a slightly significant association with voiding symptom score (p ¼ 0.035). However, other parameters, such as age, body mass index, or IPP, had no correlation with IPSS, although IPP had only a slightly significant association with storage symptom score (p ¼ 0.039). Table 5 highlights the relationship between Q max and the independent prostatic parameters. We find that PUA has a negative correlation with Q max (p < 0.001), whereas the other parameters do not. Table 6 demonstrates the relationship between postvoiding residual urine and prostatic parameters. This table shows that none of the parameters are associated with the postvoiding residual urine.
Discussion
TRUS is an accurate study that can be carried out at an outpatient clinic to evaluate the anatomical structure of the prostate. 12 The prostatic urethra can be seen clearly on the sagittal view. It runs through the prostate from the base to the apex, at an angle involving the proximal part of the verumontanum. This angle is defined as the PUA. 13 An increased PUA may be the result of a high bladder neck, which is suspected as a clinically significant causal factor of male LUTS. 8 Because there are many factors other than prostate that may affect voiding, patient selection is very important with regard to this study. To avoid other factors that may influence our study, we excluded the patients who had any neurologic disorder that could affect voiding function, uncontrolled diabetes mellitus, or any malignant disease. Those who had taken alpha blockers, had a history of prostate surgery, or presented with indwelling urinary catheter were also excluded.
The results of our study can explain the clinical findings that the severity of LUTS and the urinary flow rate are not relative to prostate size. On the contrary, PUA plays a very important role. In our study, PUA has a significant association with IPSS and Q max . This clinical finding is compatible with that of the previous related literature. A study by Bang et al 14 demonstrated that PUA has strong relationship with Q max and IPSS in men with LUTS. Ku et al 13 found
that PUA correlates with the bladder outlet obstruction (BOO) index. In other words, as PUA increases, the severity of BOO also increases.
13
IPP has been regarded as another possible prostatic parameter associated with voiding function. Chia et al 15 suggests that IPP causes a "ball-valve" type of obstruction. It disrupts the funneling effect of the bladder neck, causing dyskinesia of the bladder during voiding. The IPP is a more reliable predictor of BOO than the prostate volume, and a greater IPP was associated with a higher BOO index. 15 According to Table 2 , the mean IPP of the patients whose IPSS scores are < 20 is smaller than that of patients whose IPSS scores are > 20 (p ¼ 0.012). It seems that IPP has relationship with IPSS. However, to avoid any statistical pitfalls and to make the study more precise, we further investigated the relationship between IPP and IPSS by means of multivariate linear regression analysis. Soon afterward, we found that IPP has no linear correlation with either IPSS (p ¼ 0.543) or Q max (p ¼ 0.162), as shown in Tables 4 and 5 . Our study result is different from that reported previously by other scholars. One possible reason for this might be that the mean IPP of our patients is only 4.82 mm. However, the study by Keqin et al 16 showed that the impact on the BOO will be significant only when the IPP is > 10 mm. Therefore, most of our patients' IPP are too short to reveal the correlation between IPSS and Q max . This study has a number of limitations that should be highlighted. First of all, the PUA is measured at resting status, and not at voiding status. In fact, prostatic urethral anatomy can be altered during micturition, and PUA may not reflect the anatomy of the prostatic urethra during voiding. 17 Second, to evaluate the severity of BOO, pressure-flow examination measured by urodynamic investigations is a more accurate method, 18 although it is an unpleasant examination for the patients to undergo. Using uroflowmetry and bladder scan alone to evaluate the patients' voiding function might make the accuracy questionable. However, we believe that our study results are still valid. According to the study of Kuo et al, video-pressure-flow study is not necessary for every patient when evaluating their BOO. On the contrary, patients with LUTS can be diagnosed with a good sensitivity and specificity by combining uroflowmetry and TRUS. 7 We intend to make this current study an ongoing study. Thus, our future aim will be to focus on recruiting more patients, investigating how PUA influences the treatment efficacy of alpha blockers, and probing whether 5-alpha reductase inhibitors alter a patients' PUA after the treatment.
Conclusion
The results of our study reveal that as the PUA is increased, the patient's voiding symptoms worsened, and the urinary flow rate decreased, exhibiting an inverse relationship. The urinary flow rate and the severity of LUTS in men with benign prostatic hyperplasia are significantly affected by PUA, but not by prostate volume.
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